Narmada Gelatines
SHAWGELTINBSE

Narmada Gelatines

₹347.10-4.70 (1.34%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
341.05
Today’s high
350.00
52 week low
300.00
52 week high
415.55
Open price
345.35
Previous close
351.80
Live volume
603
Lower circuit
281.45
Upper circuit
422.15

Fundamentals

Market Cap
₹213Cr
ROE
16.90%
P/E Ratio(TTM)
8.79
EPS(TTM)
40.04
P/B Ratio
1.70
Dividend Yield
2.84%
Industry P/E
36.47
Book Value
206.34
Debt to Equity
0.10
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Narmada Gelatines Limited primarily manufactures and sells gelatine, a natural protein, along with related products such as ossein and di-calcium phosphate used in key sectors. The company focuses on long-term value creation for its investors by applying diligence to business decisions and protecting the interests of all its stakeholders. It is dedicated to maintaining the highest standards of quality for its products and services, retaining key certifications like ISO 9001:2015 and ISO 22000:2005. Its gelatine products are vital in the pharmaceutical sector for manufacturing capsules and coating tablets, and also have numerous biomedical applications for healing wounds. The applications for gelatine extend across various other industries, including food & beverage, photography, personal care, and other important technical areas. Financially, the company's earnings before interest, taxes, and depreciation (EBITDA) stood at ₹22.87 crores, marking a growth of 3.78% over the previous year.;
MD/CEO
Ashok K Kapur
Founded in
1961
BSE symbol
526739
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
75.00%
Retail And Others
24.99%
Other Domestic Institutions
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹256.35
-3.50 (1.35%)
L
    H
    4,108.48-14.23139.77
    ₹2,033.55
    +56.85 (2.88%)
    L
      H
      3,943.5252.6811.61
      EpigralEPIGRAL
      ₹883.50
      +14.45 (1.66%)
      L
        H
        3,751.1411.11.79
        ₹507.15
        +10.00 (2.01%)
        L
          H
          3,356.0024.363.35
          2026
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date

          15
          Sep
          Dividend
          Ex date
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date15 Sep ‘25
          Record Date15 Sep ‘25
          Announcement date24 May ‘25
          13
          Aug
          Quarterly Result
          Release date

          24
          May
          Dividend
          Announced
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date15 Sep ‘25
          Record Date15 Sep ‘25
          Announcement date24 May ‘25
          2024

          17
          Sep
          Dividend
          Ex date
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date17 Sep ‘24
          Record Date18 Sep ‘24
          Announcement date21 May ‘24

          21
          May
          Dividend
          Announced
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date17 Sep ‘24
          Record Date18 Sep ‘24
          Announcement date21 May ‘24
          Events calendar
          View upcoming events in other stocks